- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07845968
Comparative Effects of Advanced Neuromuscular and Dynamic Balance Training Among Hockey Players
Comparative Effects of Advanced Neuromuscular and Dynamic Balance Training on Strength , Balance and Functional Performance Among Hockey Players
This randomized clinical trial aims to compare the effects of advanced neuromuscular training and dynamic balance training on strength, balance, and functional performance among male hockey players. A total of 34 participants will be randomly allocated into two intervention groups. Both groups will receive supervised training sessions three times per week for six weeks. Outcomes including lower limb strength, dynamic balance and agility will be assessed before and after the intervention using validated assessment tools. The findings of this study will help determine which training approach is more effective for improving athletic performance and reducing the risk of injury in hockey players.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Gojra, Punjab Province, Pakistan, 36120
- Gojra Hockey Stadium
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
• Male participants aged 18 to 25 years. (34)
- Participants must be licensed, competitive hockey players (field or ice hockey) actively engaged in league play or elite training. (29)
- Participants should have a minimum of one year of competitive hockey experience. (35)
- Free from lower limb injuries for a minimum of six months before assessment. (6)
- No prior functional/neuromuscular training experience. (36)
- Participants should be actively participating in physical activity for at least 30 minutes per day, three days per week. (37)
Exclusion Criteria:
-
• History of musculoskeletal injuries within the past 12 months.
- Medical conditions that could limit involvement in training or influence assessment results. (29)
- Recent involvement in other balance or neuromuscular training programs. (17)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ADVANCED NEUROMUSCULAR TRAINING
Participants in this group receive an advanced neuromuscular training program focusing on strength, proprioception, agility, and coordination exercises. The training includes progressive drills designed to improve neuromuscular control, dynamic stability, and functional performance. Sessions are conducted under supervision over the study duration as per protocol. |
A structured advanced neuromuscular training program including strength, proprioception, agility, and coordination exercises aimed at improving neuromuscular control and dynamic stability. The program is conducted under supervision according to the study protocol. |
|
Active Comparator: DYNAMIC BALANCE TRAINING
Participants in this group receive a dynamic balance training program consisting of exercises aimed at improving postural control, balance, and stability during movement. The program includes dynamic tasks such as balance board activities and controlled movement exercises performed under supervision throughout the study period. |
A dynamic balance training program consisting of exercises designed to improve postural control, balance, and movement stability. The training includes dynamic tasks performed under supervision throughout the study period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Star Excursion Balance Test
Time Frame: [Time Frame: 6 weeks]
|
It is a dynamic balance test that assesses neuromuscular control and postural stability during multi-directional reaching tasks while standing on one leg. It demonstrates high reliability (ICC = 0.85-0.96) and good validity in identifying lower limb deficits, especially following ankle sprains and in athletic populations. Pre and post assessment will be done. |
[Time Frame: 6 weeks]
|
|
Single-Leg Hop Distance
Time Frame: [Time Frame: 6 weeks]
|
It evaluates single-leg functional performance by measuring the maximum horizontal distance achieved during a single forward hop on one leg. The Single-Leg Hop Test will be used to assess lower limb functional performance and dynamic control. The hopping distance will be measured in centimeters (cm). Pre and post assessment will be done. |
[Time Frame: 6 weeks]
|
|
Triple Hop Distance
Time Frame: [Time Frame: 6 weeks]
|
It evaluates single-leg functional performance by measuring the maximum horizontal distance achieved during three consecutive forward hops on the same leg. The Triple Hop Test will be used to assess lower limb functional performance, power, and dynamic stability. The total hopping distance will be measured in centimeters (cm). Pre and post assessment will be done. |
[Time Frame: 6 weeks]
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sidra Shafique, MS, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REC/RCR & AHS/25/0440
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.